Bonaventura, A. http://orcid.org/0000-0002-4747-5535
Grossi, F. http://orcid.org/0000-0001-8412-3136
Carbone, F. http://orcid.org/0000-0003-2957-4078
Vecchié, A. http://orcid.org/0000-0003-0410-5996
Minetti, S.
Bardi, N.
Elia, E.
Ansaldo, A. M.
Ferrara, D.
Rijavec, E.
Dal Bello, M. G.
Rossi, G. http://orcid.org/0000-0001-8432-5408
Biello, F.
Tagliamento, M.
Alama, A. http://orcid.org/0000-0002-9726-201X
Coco, S. http://orcid.org/0000-0002-5296-4325
Spallarossa, P.
Dallegri, F. http://orcid.org/0000-0001-9537-4547
Genova, C. http://orcid.org/0000-0003-3690-8582
Montecucco, F. http://orcid.org/0000-0003-0823-8729
Funding for this research was provided by:
Ministero della Salute (Rete Cardiovascolare, Ricerca Corrente)
Fondazione Cassa di Risparmio di Genova e Imperia (#2754291)
Article History
Received: 5 December 2019
Accepted: 18 January 2020
First Online: 11 February 2020
Compliance with ethical standards
:
: Francesco Grossi has consulting/advisory relationship with and received honoraria from Bristol-Myers Squibb, Merck Sharp & Dohme, and Pierre Fabre, and has consulting/advisory relationship with AstraZeneca and Roche. Carlo Genova received honoraria from AstraZeneca, Boehringer-Ingelheim, Bristol-Myers-Squibb, Merck Sharp & Dohme, and Roche. Erika Rijavec received honoraria from Bristol-Myers Squibb. Paolo Spallarossa has consulting/advisory relationship with Incyte, Teva, and Bristol-Myers Squibb, and received honoraria from Incyte, Teva, and Servier. The other authors indicated no financial relationship.